Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 296
Filtrar
1.
Toxins (Basel) ; 16(8)2024 Jul 31.
Artículo en Inglés | MEDLINE | ID: mdl-39195746

RESUMEN

Spinal cord injury (SCI) often leads to neurogenic lower urinary tract dysfunction, causing dysuria and affecting patients' well-being. This study aimed to evaluate the efficacy of a urethral sphincter botulinum toxin A (BoNT-A) injection in patients with SCI and dysuria. This was a retrospective study including 118 patients with SCI who underwent a urethral BoNT-A injection following a standardized protocol for refractory voiding dysfunction. The protocol involved injecting BoNT-A into the urethral sphincter under cystoscopic guidance. Patient demographics, bladder condition parameters, and treatment outcomes were analyzed. Logistic regression and receiver operating characteristic curve analyses were performed to identify predictors of treatment success. Of the 118 patients, 71 (60.1%) showed satisfactory treatment outcomes after the injection. Post-injection status, bladder management, and injection frequency varied significantly among patients with satisfactory and unsatisfactory treatment outcomes. Age, bladder compliance, intravesical pressure, and bladder contractility were indicators of satisfactory outcomes. The first sensation of bladder filling of ≤263 mL, intravesical pressure of ≤28, and bladder contractility index of ≥14 were highly correlated with satisfactory outcomes. A urethral sphincter BoNT-A injection shows promise in managing dysuria in patients with SCI. Understanding bladder condition parameters and patient demographics helps optimize patient selection for this intervention. Further studies are needed to validate these findings and refine treatment protocols.


Asunto(s)
Toxinas Botulínicas Tipo A , Disuria , Traumatismos de la Médula Espinal , Uretra , Humanos , Toxinas Botulínicas Tipo A/administración & dosificación , Toxinas Botulínicas Tipo A/uso terapéutico , Traumatismos de la Médula Espinal/tratamiento farmacológico , Traumatismos de la Médula Espinal/complicaciones , Estudios Retrospectivos , Disuria/tratamiento farmacológico , Disuria/etiología , Masculino , Persona de Mediana Edad , Adulto , Uretra/efectos de los fármacos , Femenino , Resultado del Tratamiento , Anciano , Fármacos Neuromusculares/administración & dosificación , Fármacos Neuromusculares/uso terapéutico , Adulto Joven , Inyecciones , Vejiga Urinaria Neurogénica/tratamiento farmacológico , Vejiga Urinaria/efectos de los fármacos
3.
Medicine (Baltimore) ; 103(20): e37893, 2024 May 17.
Artículo en Inglés | MEDLINE | ID: mdl-38758882

RESUMEN

RATIONALE: Leiomyoma is a benign smooth muscle tumor which is rarely found in urethra. We hereby report a case of a 44-year-old female who presented with complaints of dysuria. PATIENT CONCERNS: A 44-year-old female patient presented to the urology outpatient clinic with symptoms of dysuria. The patient described the presence of a protrusion from the urethra during urination. DIAGNOSIS: Urethral leiomyoma. INTERVENTIONS: Physical examination confirmed a solid urethral mass. CT scan and USG reports indicated that the mass originated from the mid-urethra with vascularity at the base. We performed a complete resection of the urethral mass. The patient was discharged after 3 days of observation. OUTCOME: During a follow-up after 1 month, the patient reported improved urinary flow and no occurrence of hematuria. The patient recovered well after discharge. LESSON: Urethral leiomyoma is a rare benign tumor that is often misdiagnosed in clinical practice. Diagnosis requires careful clinical examination. Surgical removal usually works well. It is important to remember that in some cases of acute urinary retention, it can be caused by a complete obstruction of a mass in the urethra. Urologists should be more cautious and experienced in handling such cases.


Asunto(s)
Disuria , Leiomioma , Neoplasias Uretrales , Humanos , Femenino , Leiomioma/cirugía , Leiomioma/diagnóstico , Leiomioma/complicaciones , Leiomioma/patología , Leiomioma/diagnóstico por imagen , Adulto , Disuria/etiología , Neoplasias Uretrales/diagnóstico , Neoplasias Uretrales/cirugía , Neoplasias Uretrales/patología , Tomografía Computarizada por Rayos X
4.
Arch Esp Urol ; 77(1): 38-42, 2024 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-38374011

RESUMEN

BACKGROUND: Thoracotomy under general anaesthesia is one of the most difficult surgeries and is prone to result in postoperative complications. This study explored risk factors for postoperative dysuria in patients undergoing thoracotomy under general anaesthesia to provide a reference for the formulation and selection of subsequent clinical management programs. METHODS: Patients undergoing thoracotomy under general anaesthesia (n = 179) admitted to our hospital from June 2019 to June 2021 were selected. They were divided into dysuria group (n = 79) and normal urination group (n = 100) according to whether they had dysuria after surgery. Logistic regression analysis was conducted to explore risk factors affecting postoperative dysuria. RESULTS: Univariate analysis showed that dysuria was related to gender, age, surgical time, intraoperative and postoperative infusion volume, usage time of analgesic pump and retention time of urethral catheter (p < 0.001). Logistic regression analysis showed that male, age ≥60 years, surgical time ≥120 min, intraoperative infusion volume >1200 mL, postoperative infusion volume >800 mL, analgesic pump usage time ≥18 h and urethral catheter retention time of ≥72 h were risk factors for postoperative dysuria. CONCLUSIONS: The occurrence of postoperative dysuria in patients undergoing thoracotomy under general anaesthesia is related to gender, age, surgical time, intraoperative infusion volume, postoperative infusion volume, usage time of analgesic pump and retention time of urethral catheter. Clinical attention should be given to this patient group, and targeted intervention measures should be implemented.


Asunto(s)
Disuria , Toracotomía , Humanos , Masculino , Persona de Mediana Edad , Toracotomía/efectos adversos , Disuria/epidemiología , Disuria/etiología , Analgésicos , Anestesia General/efectos adversos , Factores de Riesgo , Dolor Postoperatorio/tratamiento farmacológico , Dolor Postoperatorio/epidemiología , Dolor Postoperatorio/etiología
6.
Int Urogynecol J ; 34(12): 3051-3058, 2023 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-37851092

RESUMEN

INTRODUCTION AND HYPOTHESIS: Dysuria is a common symptom present in several urological and gynecological conditions. Management relies on the underlying disease but may require additional symptomatic treatment. This study evaluated the combination of methenamine 250 mg and methylthioninium chloride 20 mg in the treatment of dysuria versus phenazopyridine. METHODS: This was a multicenter, single-blind, randomized, superiority clinical trial, including individuals over 18 with dysuria and a score ≥ 5 points on the pre-treatment categorical scale for pain. The primary outcome was the proportion of participants presenting excellent clinical response within 24 h after treatment. Improvement up to 72 h, time to reach improvement, sustained healing, investigators' opinion, and safety were also evaluated. RESULTS: Three hundred and fifteen participants were evaluated. Demographic characteristics and symptoms of dysuria were comparable between groups at baseline. The difference in the excellent response rate between treatments within 24 h was 12.7% (95% CI 6.16, 19.21) for pain, 9.4% (95% CI 3.32, 15.39) for burning, and 12.7% (95% CI 6.37, 18.99) for burning on urination, all in favor of the test drug, which was also superior from 36 to 48 h. Treatments were similar concerning time to reach the absence of symptoms and in the percentage of participants with sustained healing after 72 h. CONCLUSIONS: The association of methenamine with methylthioninium is superior to phenazopyridine in the treatment of dysuria.


Asunto(s)
Disuria , Metenamina , Humanos , Disuria/tratamiento farmacológico , Disuria/etiología , Azul de Metileno , Dolor , Fenazopiridina/uso terapéutico , Método Simple Ciego , Adulto
7.
J Vet Intern Med ; 37(6): 2488-2491, 2023.
Artículo en Inglés | MEDLINE | ID: mdl-37772480

RESUMEN

CASE DESCRIPTION: A 4-year-old female spayed mixed breed dog presented with a 2-year history of painful urination and recurrent hematuria. CLINICAL FINDINGS: The dog had a large sensitive bladder, palpation of which was followed by painful urination. Pollakiuria accompanied by vocalization were noted during observation of voiding. DIAGNOSTICS: Cystoscopy identified a focal, rounded expansion of epithelial tissue in the right lateral aspect of the urethral papilla containing purulent material consistent with an abscess. A sample submitted for culture yielded growth of Staphylococcus pseudintermedius and Proteus mirabilis. TREATMENT AND OUTCOME: Purulent material was expelled by manual pressure during cystourethroscopy. Enrofloxacin (10 mg/kg PO q24h for 42 days) and carprofen (4.4 mg/kg PO q24h for 14 days) were initiated. Clinical signs resolved within 2 days. CLINICAL RELEVANCE: Inflammation in the region of the lesser vestibular paraurethral glands should be considered as a differential for female dogs presenting with chronic dysuria.


Asunto(s)
Enfermedades de los Perros , Vejiga Urinaria , Femenino , Perros , Animales , Uretra , Inflamación/veterinaria , Cistoscopía/veterinaria , Disuria/etiología , Disuria/veterinaria , Enfermedades de los Perros/diagnóstico , Enfermedades de los Perros/tratamiento farmacológico
8.
Ann Emerg Med ; 80(6): 565-576, 2022 12.
Artículo en Inglés | MEDLINE | ID: mdl-36403997
12.
J Med Case Rep ; 16(1): 223, 2022 May 24.
Artículo en Inglés | MEDLINE | ID: mdl-35606870

RESUMEN

BACKGROUND: Women with female genital mutilation/cutting are known to have psychological sequelae from the cutting and other traumatic experiences. However, very few studies report immediate psychological sequelae of genital reconstructive surgery in this population. The present case is the first to our knowledge to report post-traumatic stress disorder symptoms immediately following defibulation, a procedure common in women with female genital mutilation/cutting type III. CASE PRESENTATION: We present the case of a 31-year-old Sudanese nulliparous woman in the second trimester of pregnancy with female genital mutilation/cutting type IIIa who was referred for antepartum defibulation to facilitate a vaginal birth. Immediately after an uncomplicated surgery under local anesthesia and just before the first micturition, she developed post-traumatic stress disorder symptoms and suddenly recalled the traumatic experience of her first micturition after female genital mutilation/cutting when she was a child in Sudan. The woman was offered psychiatric follow-up with psychotherapy for 4 months and a short course of benzodiazepines. She had fully recovered by the time of delivery, 4 months after surgery. CONCLUSIONS: We discuss the possibility of recall of a past traumatic experience of female genital mutilation/cutting during defibulation or other genital surgeries. We review the benefits and risks of defibulation, the impact of this procedure, and the setting and timing in which it is performed, focusing on women's mental health and psychological support.


Asunto(s)
Circuncisión Femenina , Procedimientos de Cirugía Plástica , Trauma Psicológico , Trastornos por Estrés Postraumático , Adulto , Niño , Circuncisión Femenina/efectos adversos , Circuncisión Femenina/psicología , Disuria/etiología , Disuria/psicología , Femenino , Humanos , Recuerdo Mental , Embarazo , Trauma Psicológico/etiología , Trauma Psicológico/psicología , Procedimientos de Cirugía Plástica/efectos adversos , Procedimientos de Cirugía Plástica/psicología , Trastornos por Estrés Postraumático/etiología , Trastornos por Estrés Postraumático/psicología , Sudán , Micción , Trastornos Urinarios/etiología , Trastornos Urinarios/psicología , Vagina/cirugía
13.
Ann Emerg Med ; 79(5): e103-e104, 2022 05.
Artículo en Inglés | MEDLINE | ID: mdl-35461588
18.
Pan Afr Med J ; 39: 285, 2021.
Artículo en Francés | MEDLINE | ID: mdl-34754362

RESUMEN

Solitary fibrous tumour is usually a benign and rare mesenchymal tumour. The first case was reported in patients with pleural involvement. Solitary fibrous tumour of the prostate is exceptional. We here report the case of a 77-year-old patient presenting with lower urinary tract symptoms such as dysuria and polalkiuria. CT scan and MRI showed the prostate lesion and determined its relation to adjacent healthy structures, an important factor in evaluating tumour resectability. Transrectal biopsy with immunohistochemical examination confirmed the diagnosis; CD34, Bcl2 and CD 99 were expressed. Radical prostatectomy was performed.


Asunto(s)
Síntomas del Sistema Urinario Inferior/etiología , Neoplasias de la Próstata/diagnóstico , Tumores Fibrosos Solitarios/diagnóstico , Anciano , Biopsia/métodos , Disuria/etiología , Humanos , Imagen por Resonancia Magnética , Masculino , Prostatectomía/métodos , Neoplasias de la Próstata/patología , Neoplasias de la Próstata/cirugía , Tumores Fibrosos Solitarios/patología , Tumores Fibrosos Solitarios/cirugía , Tomografía Computarizada por Rayos X
19.
Hinyokika Kiyo ; 67(8): 381-384, 2021 Aug.
Artículo en Japonés | MEDLINE | ID: mdl-34472320

RESUMEN

Ectopic ureteroceles is sometimes noted in children as an incidental finding in antenatal ultrasonography results or because of symptoms related to a urinary tract infection. In contrast, it is rarely noted in adults, with only 18 cases in Japan presented in literature. We report here a 30-year-old adult male with an ectopic ureterocele discovered due to urination difficulty. The patient noted a poor urine stream and macroscopic hematuria after exercise, and over time needed manual compression on the lower abdomen for urination. Computed tomography results revealed a 35 mm right ureterocele containing a 7.0 mm stone. Cystoscopy showed the ureterocele protruding into the prostatic urethra, which was thought to be the cause of urination difficulty. Transurethral resection of the ureterocele and lithotripsy for the stone were performed. The right ureteral orifice was not visualized during the operation. Resection was performed from the bladder neck side so that the ureterocele wall did not interfere with urination and the calculus was crushed with a pneumatic lithotripter (LithoClast®). Urination difficulty was improved following the procedures. Urinary cystourethrography performed two weeks postoperatively confirmed no vesicoureteral reflux. No symptoms of dysuria or fever were noted at a follow-up visit two months after the operation.


Asunto(s)
Uréter , Ureterocele , Reflujo Vesicoureteral , Adulto , Niño , Disuria/etiología , Femenino , Humanos , Masculino , Embarazo , Ureterocele/complicaciones , Ureterocele/diagnóstico por imagen , Ureterocele/cirugía , Micción
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...